Medicus Pharma (MDCX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MDCX Medicus Pharma

Watchlist

2.890
+0.429+17.44%

Close Dec 3 16:00 ET

34.15MMarket Cap-1396P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Medicus Pharma Eyes Pivotal Trial for Novel Skin Cancer Therapy as Phase 2 Enrollment Progresses | TSX-V:MDCX, NASDAQ:MDCX
Proactive InvestorsDec 2 14:44 ET
Medicus Pharma Enters Collaboration Agreement With Swanielle
TipRanksDec 2 07:40 ET
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
newsfileDec 2 07:30 ET
Medicus Pharma Ltd. Expands With Strategic Takeover
TipRanksNov 25 08:30 ET
6-K: Report of foreign private issuer (related to financial reporting)
SECNov 25 08:02 ET · Announcements
Medicus Pharma Unveils Ex-GSK and Pfizer Senior as Chief Medical Officer | TSX-V:MDCX, NASDAQ:MDCX
Proactive InvestorsNov 18 08:44 ET

Comments

Stock_Drift

17 hours ago

Low Floats. 3:18pm

$Altamira Therapeutics (CYTO.US)$ $ATI Physical Therapy (ATIP.US)$ $Prestige Wealth (PWM.US)$ $Serina Therapeutics (SER.US)$ $Auddia (AUUD.US)$ $Creative Global Technology (CGTL.US)$ $Ambow Education (AMBO.US)$ $Quoin Pharmaceuticals (QNRX.US)$ $Citius Oncology (CTOR.US)$ $Medicus Pharma (MDCX.US)$ $Kindly MD (KDLY.US)$ $Jayud Global Logistics Ltd. (JYD.US)$ $Cheetah Net Supply Chain Service (CTNT.US)$
📊⚡️📊

Jaguar8

Dec 2 06:30

NEWS

$Medicus Pharma (MDCX.US)$
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
Monday, 2nd December at 7:30 am
TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce an agreement with Swanielle Inc. ("Swanielle") to explore expansion of Phase 2 clinical study for treatment of Basal Cell Carcinoma (BCC) in the Asia-pacific region
.
Under the agreemen...